These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Determinants of lipid goal achievement in patients on extended-release nicotinic acid/laropiprant in primary care clinical practice. Dänschel W; Steinhagen-Thiessen E; Buffleben C; Pittrow D; Hildemann SK Curr Med Res Opin; 2013 Jan; 29(1):33-40. PubMed ID: 23157464 [TBL] [Abstract][Full Text] [Related]
8. [Lowering LDL cholesterol. How much is enough?]. März W; Grammer TB Internist (Berl); 2007 Mar; 48(3):319-26. PubMed ID: 17333056 [TBL] [Abstract][Full Text] [Related]
9. [Lipid control in patients with coronary artery disease in a healthcare area in Cáceres (Spain): LIPICERES study]. Gómez-Barrado JJ; Ortiz C; Gómez-Turégano M; Gómez-Turégano P; Garcipérez-de-Vargas FJ; Sánchez-Calderón P Clin Investig Arterioscler; 2017; 29(1):13-19. PubMed ID: 28062171 [TBL] [Abstract][Full Text] [Related]
10. Angiographic evidence that treatment of lipoprotein abnormalities prevents progression of coronary atherosclerosis. Olsson AG Eur Heart J; 1987 Aug; 8 Suppl E():55-8. PubMed ID: 3315678 [No Abstract] [Full Text] [Related]
11. Focus on HDL as a therapeutic target for CAD risk reduction. Davidson MH Am J Cardiol; 2009 Nov; 104(10 Suppl):1E-2E. PubMed ID: 19895937 [No Abstract] [Full Text] [Related]
12. [Editorial comment: lipoprotein (a) and coronary artery disease]. Soydan I Anadolu Kardiyol Derg; 2001 Dec; 1(4):264-5. PubMed ID: 12803215 [No Abstract] [Full Text] [Related]
13. [Association of microalbuminuria and fasting insulin levels with presence and severity of coronary artery disease in non-diabetic cases]. Ekicibaşi E; Kaderli AA; Kazazoğlu AR; Ozdemir B Anadolu Kardiyol Derg; 2008 Feb; 8(1):16-21. PubMed ID: 18258528 [TBL] [Abstract][Full Text] [Related]
14. Association of small dense LDL with a coronary artery disease and diabetes in urban Asian Indians--the Chennai urban Asian Indians--The Chennai Urban Rural Epidemiology Study (CURES 8). Jadhav UM J Assoc Physicians India; 2005 May; 53():492-3; author reply 493. PubMed ID: 16124365 [No Abstract] [Full Text] [Related]
16. Hypertriglyceridemia and coronary heart disease. Jones JD; Chambliss ML Arch Fam Med; 2000 Feb; 9(2):189-90. PubMed ID: 10693737 [No Abstract] [Full Text] [Related]
17. [HDL-cholesterol-- active or passive participant in the pathogenesis of atherosclerosis]. Artenie R; Ungureanu D; Artenie A; Botnariu G; Anisie E Rev Med Chir Soc Med Nat Iasi; 2003; 107(2):282-7. PubMed ID: 14755929 [TBL] [Abstract][Full Text] [Related]
18. Low high-density lipoprotein cholesterol as a risk factor in coronary heart disease: a working group report. Gotto AM Circulation; 2001 May; 103(17):2213-8. PubMed ID: 11331265 [No Abstract] [Full Text] [Related]
19. Progression and regression of atherosclerosis, what roles for LDL-cholesterol and HDL-cholesterol: a perspective. Barth JD; Arntzenius AC Eur Heart J; 1991 Aug; 12(8):952-7. PubMed ID: 1915434 [TBL] [Abstract][Full Text] [Related]